{Reference Type}: Journal Article
{Title}: CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell-mediated cytotoxicity.
{Author}: Park EJ;Jun HW;Na IH;Lee HK;Yun J;Kim HS;Kim Y;Hong JT;Han SB;
{Journal}: Arch Pharm Res
{Volume}: 45
{Issue}: 1
{Year}: Jan 2022
{Factor}: 6.01
{DOI}: 10.1007/s12272-021-01365-z
{Abstract}: The susceptibility of cancer cells to natural killer (NK) cell-mediated cytotoxicity depends on the balance of activating and inhibitory ligands expressed on their surface. Although many types of cancer cells are killed by NK cells, non-small-cell lung cancer (NSCLC) cells are relatively resistant to NK cell-mediated cytotoxicity. In this study, we showed that several NSCLC cell lines have differential sensitivity to NK cell-mediated cytotoxicity: NCI-H522 cells were highly sensitive, but A549, NCI-H23, NCI-H1915, and NCI-H1299 were resistant. Among activating ligands such as CD48, HLA-A/B/G, ICAM-1, MICA/B, and ULBPs, only CD48 rendered NCI-H522 cells susceptible to NK cell-mediated cytotoxicity, which was proved by using CD48 siRNA and neutralizing antibody. CD48-positive NCI-H522 cells established a more stable contact with NK cells than did CD48-negative A549 and CD48 siRNA cell-transfected NCI-H522 cells. Taken together, these data demonstrate that CD48-positive NSCLC cells might be susceptible to NK cell-mediated cytotoxicity, which provide information on how to stratify NSCLC patients potentially responsive to NK-cell therapy.